LincRNA for kinase activation (LINK-A), an oncogenic activator of HIF1α signaling in breast cancer (Lin et al., 2016), displays a greater expression of plasma circulating LINK-A in metastatic OS patients in comparison to non-metastatic OS patients, demonstrating its potential role in OS metastasis. Here, LINC01139 is linked to breast cancer.